Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2025 | 1 | -$0.15 | -$0.15 | -$0.15 |
Q2 2025 | 1 | -$0.20 | -$0.20 | -$0.20 |
Q3 2025 | 1 | -$0.20 | -$0.20 | -$0.20 |
Q4 2025 | 1 | -$0.35 | -$0.35 | -$0.35 |
GlycoMimetics, Inc. last posted its earnings results on Thursday, February 13th, 2025. The company reported $-0.11 earnings per share for the quarter, topping analysts' consensus estimates of $-0.16 by $0.05. The company had revenue of 0 for the quarter and had revenue of 0 for the year. GlycoMimetics, Inc. has generated $-1 earnings per share over the last year ($-0.59 diluted earnings per share) and currently has a price-to-earnings ratio of -0.44. GlycoMimetics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 25th, 2025 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
02/13/2025 | Q4 2024 | -$0.16 | -$0.11 | 0.05 | $0 | $0 |
11/13/2024 | Q3 2024 | -$0.11 | -$0.15 | -0.04 | $0 | $0 |
08/08/2024 | Q2 2024 | N/A | -$0.16 | N/A | $0 | $0 |
05/09/2024 | Q1 2024 | -$0.16 | -$0.17 | -0.01 | N/A | $0 |
03/27/2024 | Q4 2023 | -$0.15 | -$0.14 | 0.01 | N/A | $10,000 |
11/03/2023 | Q3 2023 | -$0.14 | -$0.14 | 0 | N/A | $0 |
08/02/2023 | Q2 2023 | -$0.18 | -$0.13 | 0.05 | $50,000 | $0 |
05/03/2023 | Q1 2023 | -$0.17 | -$0.16 | 0.01 | N/A | $0 |
03/29/2023 | Q4 2022 | -$0.17 | -$0.55 | -0.38 | N/A | $75 |
11/09/2022 | Q3 2022 | -$0.26 | -$0.16 | 0.1 | N/A | $0 |
08/03/2022 | Q2 2022 | -$0.29 | -$0.25 | 0.04 | N/A | $75,000 |
04/28/2022 | Q1 2022 | -$0.31 | -$0.28 | 0.03 | N/A | $0 |
03/03/2022 | Q4 2021 | -$0.31 | -$0.33 | -0.02 | N/A | $18,000 |
11/02/2021 | Q3 2021 | -$0.32 | -$0.34 | -0.02 | N/A | $86,560 |
08/05/2021 | Q2 2021 | -$0.31 | -$0.28 | 0.03 | N/A | $142 |
05/03/2021 | Q1 2021 | -$0.32 | -$0.28 | 0.04 | N/A | $1.06 M |
03/02/2021 | Q4 2020 | -$0.32 | -$0.33 | -0.01 | N/A | $163,000 |
11/06/2020 | Q3 2020 | -$0.33 | -$0.29 | 0.04 | N/A | $1.00 M |
07/31/2020 | Q2 2020 | -$0.37 | -$0.32 | 0.05 | N/A | $0 |
05/01/2020 | Q1 2020 | -$0.30 | -$0.18 | 0.12 | N/A | $9.00 M |
GlycoMimetics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 25th, 2025 based offlast year's report dates.
In the previous quarter, GlycoMimetics, Inc. (:GLYC) reported $-0.11 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.16 by $0.05.
The conference call for GlycoMimetics, Inc.'s latest earnings report can be listened to online.
The conference call transcript for GlycoMimetics, Inc.'s latest earnings report can be read online.
GlycoMimetics, Inc. (:GLYC) has a price-to-earnings ratio of -0.44 and price/earnings-to-growth ratio is -0.09.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED